The high-affinity human IgG receptor FcγRI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy

Blood

Volumn 121, Issue 9, 2013, Pages 1563-1573

  Mancardi, David A ^a,b   Albanesi, Marcello ^a,c   Jönsson, Friederike ^a,b   Iannascoli, Bruno ^a,b   Van Rooijen, Nico ^d   Kang, Xiaoqiang ^e   England, Patrick ^a,f   Daëron, Marc ^a,b   Bruhns, Pierre ^a,b  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ELI LILLY AND COMPANY   (United States)

^f CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD64 ANTIGEN; FC GAMMA RECEPTOR I; FC GAMMA RECEPTOR I ANTIBODY; FC RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTHRITIS; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; MACROPHAGE; MEDIATOR; METASTATIC MELANOMA; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PASSIVE SYSTEMIC ANAPHYLAXIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; THROMBOCYTOPENIA; TRANSGENIC MOUSE;

EID: 84876463158     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-07-442541     Document Type: Article

References (50)

1. Bruhns P. Properties of mouse and human IgG receptors and their contribution to disease models. Blood. 2012;119(24):5640-5649.
2. Jonsson F, Mancardi DA, Zhao W, et al. Human FcgammaRIIA induces anaphylactic and allergic reactions. Blood. 2012;119(11):2533-2544.
3. Tan Sardjono C, Mottram PL, van de Velde NC, et al. Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcgamma receptor IIa-Transgenic mice. Arthritis Rheum. 2005;52(10):3220-3229. (Pubitemid 41447105)
4. van Royen-Kerkhof A, Sanders EA, Walraven V, et al. A novel human CD32 mAb blocks experimental immune haemolytic anaemia in FcgammaRIIA transgenic mice. Br J Haematol. 2005; 130(1):130-137. (Pubitemid 40979144)
5. Tsuboi N, Asano K, Lauterbach M, Mayadas TN. Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases. Immunity. 2008;28(6):833-846.
6. Bruhns P, Iannascoli B, England P, et al. Specificity and affinity of human Fc{gamma} receptors and their polymorphic variants for human IgG subclasses. Blood. 2009;113(16):3716-3725.
7. Mancardi DA, Iannascoli B, Hoos S, England P, Daeron M, Bruhns P. FcgammaRIV is a mouse IgE receptor that resembles macrophage FcepsilonRI in humans and promotes IgE-induced lung inflammation. J Clin Invest. 2008;118(11):3738-3750.
8. van der Poel CE, Karssemeijer RA, Boross P, et al. Cytokine-induced immune complex binding to the high-Affinity IgG receptor, FcgammaRI, in the presence of monomeric IgG. Blood. 2010; 116(24):5327-5333.
9. van Lent PL, Nabbe K, Blom AB, et al. Role of activatory Fc gamma RI and Fc gamma RIII and inhibitory Fc gamma RII in inflammation and cartilage destruction during experimental antigeninduced arthritis. Am J Pathol. 2001;159(6):2309-2320. (Pubitemid 33104284)
10. Ioan-Facsinay A, de Kimpe SJ, Hellwig SM, et al. Fc gamma RI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity. 2002;16(3):391-402. (Pubitemid 34260917)
11. Barnes N, Gavin AL, Tan PS, Mottram P, Koentgen F, Hogarth PM. FcgammaRI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity. 2002;16(3):379-389. (Pubitemid 34260916)
12. Otten MA, van der Bij GJ, Verbeek SJ, et al. Experimental antibody therapy of liver metastases reveals functional redundancy between Fc gammaRI and Fc gammaRIV. J Immunol. 2008; 181(10):6829-6836.
13. Baudino L, Nimmerjahn F, Azeredo da Silveira S, et al. Differential contribution of three activating IgG Fc receptors (FcgammaRI, FcgammaRIII, and FcgammaRIV) to IgG2a-And IgG2b-induced autoimmune hemolytic anemia in mice. J Immunol. 2008;180(3):1948-1953.
14. Marjon KD, Marnell LL, Mold C, Du Clos TW. Macrophages activated by C-reactive protein through Fc gamma RI transfer suppression of immune thrombocytopenia. J Immunol. 2009; 182(3):1397-1403.
15. Biburger M, Aschermann S, Schwab I, et al. Monocyte subsets responsible for immunoglobulin G-dependent effector functions in vivo. Immunity. 2011;35(6):932-944.
16. Tan PS, Gavin AL, Barnes N, et al. Unique monoclonal antibodies define expression of Fc gamma RI on macrophages and mast cell lines and demonstrate heterogeneity among subcutaneous and other dendritic cells. J Immunol. 2003;170(5): 2549-2556. (Pubitemid 36245645)
17. Mancardi DA, Jonsson F, Iannascoli B, et al. The murine high-Affinity IgG receptor Fc(gamma)RIV is sufficient for autoantibody-induced arthritis. J Immunol. 2011;186(4):1899-1903.
18. Langlet C, Tamoutounour S, Henri S, et al. CD64 Expression Distinguishes Monocyte-Derived and Conventional Dendritic Cells and Reveals Their Distinct Role during Intramuscular Immunization. J Immunol. 2012;188(4):1751-1760.
19. Bruhns P, Samuelsson A, Pollard JW, Ravetch JV. Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity. 2003;18(4):573-581. (Pubitemid 36513638)
20. Nimmerjahn F, Ravetch JV. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science. 2005;310(5753):1510-1512. (Pubitemid 41746349)
21. Jonsson F, Mancardi DA, Kita Y, et al. Mouse and human neutrophils induce anaphylaxis. J Clin Invest. 2011;121(4):1484-1496.
22. Nimmerjahn F, Bruhns P, Horiuchi K, Ravetch JV. Fc gamma RIV: a novel FcR with distinct IgG subclass specificity. Immunity. 2005;23(1):41-51. (Pubitemid 41019656)
23. Quayle JA, Watson F, Bucknall RC, Edwards SW. Neutrophils from the synovial fluid of patients with rheumatoid arthritis express the high affinity immunoglobulin G receptor, Fc gamma RI (CD64): role of immune complexes and cytokines in induction of receptor expression. Immunology. 1997;91(2):266-273. (Pubitemid 27261572)
24. Bevaart L, Van Ojik HH, Sun AW, et al. CpG oligodeoxynucleotides enhance FcgammaRImediated cross presentation by dendritic cells. Int Immunol. 2004;16(8):1091-1098. (Pubitemid 39136726)
25. Ohsaka A, Saionji K, Takagi S, Igari J. Increased expression of the high-Affinity receptor for IgG (FcRI, CD64) on neutrophils in multiple myeloma. Hematopathol Mol Hematol. 1996;10(3):151-160. (Pubitemid 26383919)
26. Skokowa J, Ali SR, Felda O, et al. Macrophages induce the inflammatory response in the pulmonary Arthus reaction through G alpha i2 activation that controls C5aR and Fc receptor cooperation. J Immunol. 2005;174(5):3041-3050. (Pubitemid 40279725)
27. Solomon S, Rajasekaran N, Jeisy-Walder E, Snapper SB, Illges H. A crucial role for macrophages in the pathology of K/B x N seruminduced arthritis. Eur J Immunol. 2005;35(10): 3064-3073. (Pubitemid 41555102)
28. Syed SN, Konrad S, Wiege K, et al. Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a. Eur J Immunol. 2009;39(12):3343-3356.
29. Wipke BT, Allen PM. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol. 2001; 167(3):1601-1608. (Pubitemid 32703161)
30. Heijnen IA, van Vugt MJ, Fanger NA, et al. Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice. J Clin Invest. 1996; 97(2):331-338. (Pubitemid 26039395)
31. Magnusson SE, Engstrom M, Jacob U, Ulfgren AK, Kleinau S. High synovial expression of the inhibitory FcgammaRIIb in rheumatoid arthritis. Arthritis Res Ther. 2007;9(3):R51.
32. Strait RT, Morris SC, Yang M, Qu XW, Finkelman FD. Pathways of anaphylaxis in the mouse. J Allergy Clin Immunol. 2002;109(4):658-668. (Pubitemid 34327194)
33. Strait RT, Hicks W, Barasa N, et al. MHC class I-specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in mice. J Exp Med. 2011;208(12):2525- 2544.
34. Van den Berg CW, Aerts PC, Van Dijk H. In vivo anti-complementary activities of the cobra venom factors from Naja naja and Naja haje. J Immunol Methods. 1991;136(2):287-294.
35. Makabe-Kobayashi Y, Hori Y, Adachi T, et al. The control effect of histamine on body temperature and respiratory function in IgE-dependent systemic anaphylaxis. J Allergy Clin Immunol. 2002; 110(2):298-303.
36. Xu X, Zhang D, Zhang H, et al. Neutrophil histamine contributes to inflammation in mycoplasma pneumonia. J Exp Med. 2006;203(13):2907-2917. (Pubitemid 46026168)
37. Bevaart L, Jansen MJ, van Vugt MJ, Verbeek JS, van de Winkel JG, Leusen JH. The high-Affinity IgG receptor, FcgammaRI, plays a central role in antibody therapy of experimental melanoma. Cancer Res. 2006;66(3):1261-1264. (Pubitemid 43259901)
38. Albanesi M, Mancardi DA, Macdonald LE, et al. Cutting edge: FcgammaRIII (CD16) and FcgammaRI (CD64) are responsible for antiglycoprotein 75 monoclonal antibody TA99 therapy for experimental metastatic B16 melanoma. J Immunol. 2012;189(12):5513-5517.
39. Patel D, Balderes P, Lahiji A, et al. Generation and characterization of a therapeutic human antibody to melanoma antigen TYRP1. Hum Antibodies. 2007;16(3-4):127-136. (Pubitemid 351359902)
40. Nimmerjahn F, Ravetch JV. Fcgamma receptors: old friends and new family members. Immunity. 2006;24(1):19-28. (Pubitemid 43077197)
41. Paetz A, Sack M, Thepen T, et al. Recombinant soluble human Fcgamma receptor I with picomolar affinity for immunoglobulin G. Biochem Biophys Res Commun. 2005;338(4):1811-1817. (Pubitemid 41643095)
42. Okayama Y, Kirshenbaum AS, Metcalfe DD. Expression of a functional high-Affinity IgG receptor, Fc gamma RI, on human mast cells: Up-regulation by IFN-gamma. J Immunol. 2000;164(8):4332-4339. (Pubitemid 30215096)
43. Zhao W, Kepley CL, Morel PA, Okumoto LM, Fukuoka Y, Schwartz LB. Fc gamma RIIa, not Fc gamma RIIb, is constitutively and functionally expressed on skin-derived human mast cells. J Immunol. 2006;177(1):694-701. (Pubitemid 43939184)
44. Smith P, Dilillo DJ, Bournazos S, Li F, Ravetch JV. Mouse model recapitulating human Fcgamma receptor structural and functional diversity. Proc Natl Acad Sci U S A. 2012;109(16):6181-6186.
45. Roopenian DC, Akilesh S. FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol. 2007; 7(9):715-725. (Pubitemid 47327396)
46. Ober RJ, Radu CG, Ghetie V, Ward ES. Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies. Int Immunol. 2001;13(12):1551-1559. (Pubitemid 33133882)
47. Nimmerjahn F, Lux A, Albert H, et al. FcgammaRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo. Proc Natl Acad Sci U S A. 2010;107(45):19396-19401.
48. Keler T, Graziano RF, Mandal A, et al. Bispecific antibody-dependent cellular cytotoxicity of HER2/neu-overexpressing tumor cells by Fc gamma receptor type I-expressing effector cells. Cancer Res. 1997;57(18):4008-4014. (Pubitemid 27427690)
49. Stockmeyer B, Schiller M, Repp R, et al. Enhanced killing of B lymphoma cells by granulocyte colony-stimulating factor-rimed effector cells and Hu1D10-A humanized human leucocyte antigen DR antibody. Br J Haematol. 2002; 118(4):959-967. (Pubitemid 35025957)
50. Schweizer C, Strauss G, Lindner M, Marme A, Deo YM, Moldenhauer G. Efficient carcinoma cell killing by activated polymorphonuclear neutrophils targeted with an Ep-CAMxCD64 (HEA125x197) bispecific antibody. Cancer Immunol Immunother. 2002;51(11-12):621-629. (Pubitemid 35440515)